| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 04/04/2006 | USH2154 Process for preparing R- and S-isomers of (R)-5-(2-( (2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide |
| 04/04/2006 | US7022851 A peptide nucleic acid derivatives comprising a N-acetyl-1-(2-nitro-phenensulfonyl)-peperazin-2-one core group; oligomerization, for specific binding to DNA as well as RNA, stability |
| 04/04/2006 | US7022738 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 04/04/2006 | US7022689 5-amidino-n-(2-aminophenethyl)-n-hydroxy-benzenesulffonamide derivative, medical composition containing the same, pharmaceutical use thereof and intermediate therefor |
| 03/30/2006 | WO2006034333A2 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives |
| 03/30/2006 | US20060069286 Sulfonamide compounds |
| 03/30/2006 | US20060069264 Aza hydroxylated ethyl amine compounds |
| 03/30/2006 | US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 03/29/2006 | EP1638924A1 Pesticidally active ketone and oxime derivatives |
| 03/29/2006 | EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor |
| 03/29/2006 | CN1247538C Alkyl sulfonamide phenyl alkylamide compound and its prepn and medicinal use |
| 03/29/2006 | CN1247523C Substituted 1 and 2 naphthol mannich bases |
| 03/29/2006 | CN1247511C Tropolone derivative |
| 03/28/2006 | US7019033 For therapy of cancer and other proliferative diseases such as inflammation, psoriasis and restenosis, as well as stroke, heart failure, and immunodeficiency disorders |
| 03/28/2006 | CA2125104C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/23/2006 | WO2005121078A3 Substituted cyclopentene compounds |
| 03/23/2006 | WO2005040102A3 Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| 03/23/2006 | WO2004087057A3 Methods for inhibition of angiogenesis |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063841 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives |
| 03/23/2006 | US20060063769 Preventives/remedies for urinary disturbance |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | DE102004045825A1 Lyophilisat enthaltend N-Diaminomethylen-2-methyl-4,5-di-(methylsulfonyl)-benzamid Lyophilisate containing N-diaminomethylene-2-methyl-4,5-di (methylsulfonyl) benzamide |
| 03/23/2006 | CA2580131A1 Substituted aniline derivatives |
| 03/22/2006 | EP1637518A2 Inhibitors of aspartyl protease |
| 03/22/2006 | EP1636174A1 Inhibitors of matrix metalloproteinase |
| 03/22/2006 | EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 03/22/2006 | EP1029541B1 Therapeutic or prophylactic agent for glomerulopathy |
| 03/22/2006 | CN1751101A Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 03/22/2006 | CN1751037A Sulfonamide derivatives as PPAR modulators |
| 03/22/2006 | CN1749243A Synthetic method for thia bizolyl azo trifluoro methane sulfo aniline derivative |
| 03/22/2006 | CN1246300C Resorcinol derivatives |
| 03/22/2006 | CN1246041C Solid-phase nucleophilic fluorination |
| 03/21/2006 | CA2244140C Alkylated styrenes as prodrugs to cox-2 inhibitors |
| 03/21/2006 | CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 03/21/2006 | CA2072416C Cyclopropenone derivatives |
| 03/16/2006 | WO2006028038A1 Sulfonamide derivative selectively inhibiting mmp-13 |
| 03/16/2006 | US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 03/16/2006 | US20060058389 Novel compounds that inhibit factor xa activity |
| 03/16/2006 | US20060058373 Novel substituted sulfamate anticonvulsant derivatives |
| 03/16/2006 | US20060058315 2-Oxo-ethanesulfonamide derivates |
| 03/16/2006 | US20060058298 Inhibitors of histone deacetylase |
| 03/15/2006 | EP1635218A2 Photosensitive composition, compound for use in the photosensitive composition, and pattern-forming method using the photosensitive composition |
| 03/15/2006 | EP1633354A2 N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
| 03/15/2006 | EP0997147B1 Amino acid derivatives |
| 03/15/2006 | CN1245380C Anthranilic acid derivatives |
| 03/14/2006 | US7012161 Compound, fluorine-containing polymerizable cyclic olefin compound |
| 03/14/2006 | US7012094 such as 3-(4-fluorophenyl)-4-(methylsulfonylphenyl)furan; for treatment of arthritis |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2147984C Butenyl-substituted taxanes and composition |
| 03/09/2006 | WO2006025482A1 Proton conductor and fuel cell using the same |
| 03/09/2006 | WO2006024779A1 Sulphonamide derivatives, their preparation and their therapeutic application |
| 03/09/2006 | WO2005060692A3 Biphenyl compounds and methods |
| 03/09/2006 | WO2004089296A3 Improved inhibitors for the soluble epoxide hydrolase |
| 03/09/2006 | US20060052615 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 03/09/2006 | US20060052600 Amino-functional chalcones |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052388 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 03/09/2006 | CA2577220A1 Sulphonamide derivatives, their preparation and their therapeutic application |
| 03/08/2006 | EP1631995A2 Manufacture of a polymer device |
| 03/08/2006 | EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | CN1744890A Labeled macrophage scavenger receptor antagonists for imaging cardiovacular diseases |
| 03/08/2006 | CN1244575C Sulfonyl alkylamido hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 03/08/2006 | CN1244565C New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 03/07/2006 | US7009077 Aromatic sulfonation reactions |
| 03/07/2006 | US7009065 bidentate organophosphorous ferrocenyl ligands that create a highly asymmetric coordination sphere |
| 03/02/2006 | US20060047138 chloramphenicols; e.g. D-(threo)-1-p-methylsulfonyl-2-amino-3-fluoro-1-propanol("Fenicol Compounds"); antibiotics; veterinary medicine; side effect reducion |
| 03/02/2006 | CA2576008A1 Process for the synthesis c-2, c-3 substituted n-alkylated indoles useful as cpla2 inhibitors |
| 03/01/2006 | EP1630157A1 CaSR ANTAGONIST |
| 03/01/2006 | EP1628954A2 Acylsulfamide inhibitors of factor viia |
| 03/01/2006 | EP1628953A2 Process for preparing reverse transcriptase inhibitors |
| 03/01/2006 | CN1243730C Cinnamoylaminoalkyl-substd. benzenesulfonamide derivs. |
| 03/01/2006 | CN1243728C Novel color-developing compound and recording material |
| 02/28/2006 | US7005549 such as dipropionyl sulfamide for reaction with peroxide compound; for cleaning endoscopes |
| 02/28/2006 | US7005538 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; use to treat cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 02/28/2006 | US7005437 Substituted aryl and heteroaryl derivatives, the preparation thereof and the use therof as pharmaceutical compositions |
| 02/28/2006 | CA2332535C Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/23/2006 | WO2005080324A8 Sulfonamide derivatives for the treatment of diseases |
| 02/23/2006 | US20060041014 Treatment of male sexual dysfunction |
| 02/23/2006 | US20060040979 3-Aryl-2-hydroxypropionic acid derivative I |
| 02/23/2006 | US20060040869 Pharmaceutically useful compounds |
| 02/22/2006 | EP1627869A1 Amide derivative |
| 02/22/2006 | CN1738796A Bis-aryl sulfonamides |
| 02/22/2006 | CN1736984A Anti benign prostate hypertrophy drug tamsulosin synthesis method |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/21/2006 | CA2116165C Substituted benzenesulfonylureas and -thioureas - processes for their preparation and their use as pharmaceuticals |
| 02/16/2006 | WO2006015829A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 02/16/2006 | WO2005118529A3 Process for making n-sulfonated-amino acid derivatives |
| 02/16/2006 | US20060035969 Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060035137 Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery |
| 02/16/2006 | US20060034035 Nonaqueous electrolyte, electrical double-layer capacitors, and nonaqueous electrolyte secondary cells |
| 02/16/2006 | CA2573369A1 Inhibitors of histone deacetylase |
| 02/15/2006 | EP1624868A1 "(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)- propyl!phenyl derivatives as beta2 agonists |
| 02/15/2006 | CN1733714A Fumaric acid ibutilide synthesis method |
| 02/15/2006 | CN1733707A Compounds and methods for synthesis and therapy |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/14/2006 | US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |